- 1. 3D-CRT
- [A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased. ( NCI )] (UMLS (NCI) C0600521) =Therapeutic or Preventive Procedure ;
| - 16. DCF/MP/MTX
- (UMLS (NCI) C0278933) =Therapeutic or Preventive Procedure
|
- 2. D & C and Conization
- (UMLS (HL7) C1548844) =Health Care Activity =Consent Type;
| - 17. DCIS and ILC
- (UMLS (NCI) C0334384) =Neoplastic Process
|
- 3. D & C FOR PREG TERMINAT
- [ ] (UMLS (ICD9CM) C0195641) =Therapeutic or Preventive Procedure
| - 18. DCIS and LCIS of Breast
- [The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion. ( NCI )] (UMLS (NCI) C0334383) =Neoplastic Process
|
- 4. D & C NEC
- [ ] (UMLS (ICD9CM) C0376038) =Therapeutic or Preventive Procedure
| - 19. DCIS Grade 1
- (UMLS (NCI) C1334413) DIN 1C;
Ductal Intraepithelial Neoplasia, Grade 1C;
Low Grade Ductal Breast Carcinoma In Situ;
Low-Grade DCIS;
Low-Grade Ductal Carcinoma In Situ of Breast =Neoplastic Process |
- 5. D & C POST DELIVERY
- [ ] (UMLS (ICD9CM) C0177204) =Therapeutic or Preventive Procedure
| - 20. DCIS Grade 2
- (UMLS (NCI) C1334206) DIN 2;
Ductal Intraepithelial Neoplasia, Grade 2;
Intermediate Grade Ductal Breast Carcinoma In Situ;
Intermediate-Grade DCIS;
Intermediate-Grade Ductal Carcinoma In Situ of Breast =Neoplastic Process; ;
|
- 6. D Cell
- [Cells found throughout the gastrointestinal tract and in the pancreas. They secrete somatostatin in both an endocrine and paracrine manner. (MeSH) ( NCI )] (UMLS (NCI) C0524984) =Cell ;
| - 21. DCK
- [This gene is involved in deoxyribonucleoside phosphorylation. ( NCI )] (UMLS (NCI) C1333205) DCK Gene;
Deoxycytidine Kinase Gene =Gene or Genome ;
|
- 7. D.C.
- [The area in the United States comprised of a 68 square mile area northeast of the Potomac River donated by the state of Maryland. The District of Columbia, also known as D.C., is not a state, nor is it part of any state. It is a "federal district" established by the US Constitution as the seat of government. The district is occupied entirely by the city of Washington. ( NCI )] (UMLS (NCI) C0012764) =Geographic Area ;
| - 22. DCM
- [disease of unknown cause characterized by dilation and impaired function of one or both heart ventricles. ( CSP )] (UMLS (CSP) C0264793) =Disease or Syndrome ;
=cardiomyopathy;
|
- 8. D/C
- [To stop or end, permanently or temporarily. ( NCI )] (UMLS (NCI) C1444662) dc;
disc;
Discontinuation;
Discontinue;
Discontinued;
Discontinuous =Finding ;
| - 23. DCM
- [chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations; its primary use is as a solvent in manufacturing and food technology. ( CSP )] (UMLS (NCI) C0025748) =Organic Chemical; Pharmacologic Substance ;
=chlorohydrocarbon;
haloalkane;
Inactive Ingredient Preparations;
|
- 9. DC 13116
- (UMLS (NCI) C0245668) =Amino Acid, Peptide, or Protein
| - 24. dCMP aminohydrolase
- [An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12. ( MSH )] (UMLS (CSP) C0011491) =Amino Acid, Peptide, or Protein; Enzyme ;
=aminohydrolase;
|
- 10. DC-Chol Liposomes
- [A cationic cholesterol derivative mixed with dimethylaminoethane-carbamoyl and sonicated to form small unilamellar vesicles that can complex with DNA, DNA/protein complexes and other drug complexes and mediates the delivery into the cytosol from the endosome compartment. (NCI) ( NCI )] (UMLS (NCI) C0935779) DC-Cholesterol Liposome;
Dimethylaminoethane-carbamoyl-cholesterol Liposomes =Lipid; Pharmacologic Substance | - 25. dCMP Deaminase Gene
- [This gene plays a role in pyrimidine nucleotide metabolism. ( NCI )] (UMLS (NCI) C1413934) DCTD;
DCTD Gene =Gene or Genome |
- 11. DC-Chol Liposomes/EGFR Antisense DNA
- (UMLS (NCI) C0935780) =Therapeutic or Preventive Procedure ;
| - 26. DCNU (dichlorethylnitrosourea)
- [ ] (UMLS (CSP) C0598975) =Organic Chemical; Pharmacologic Substance
|
- 12. DCC
- [This gene plays a role in the regulation of several processes involving the alteration of RNA secondary structure. ( NCI )] (UMLS (NCI) C0079414) =Gene or Genome ;
| - 27. Dcr-1 Homolog
- [Endoribonuclease Dicer, encoded by the human DICER1 gene, possesses an RNA helicase motif, containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. It is required by the RNA interference in cleaving double-stranded RNA as well as small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. The 21 to 23 bp double-stranded RNAs (siRNAs) generated target the selective destruction of homologous RNAs. (From OMIM, Swiss-Port, and NCI) ( NCI )] (UMLS (NCI) C1309483) Dicer;
DICER1;
DICER1 Protein;
EC 3.1.26.-;
Endoribonuclease Dicer;
Helicase with RNase Motif;
Helicase-MOI;
HERNA;
Homolog of Drosophila Dicer;
K12H4.8-Like;
KIAA0928 =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 13. DCF/FAMP
- (UMLS (NCI) C0279044) =Therapeutic or Preventive Procedure
| - 28. DCR3
- [Expressed in stomach, spinal cord, lymph node, trachea, spleen, colon and lung, human TNFRSF6B Gene (TNFR Family) encodes isoforms of 300-aa 33-kDa (precursor) secreted Decoy Receptor for FAS Ligand, a decoy receptor containing 4 TNFR-Cys repeats that protects against apoptosis by competing with death receptors for cytotoxic ligands TNFS14 and FasL. (NCI) ( NCI )] (UMLS (NCI) C1259595) Decoy Receptor 3;
Decoy Receptor for FAS Ligand;
M68;
TNFRSF6B;
TR6 =Amino Acid, Peptide, or Protein; Receptor ;
|
- 14. DCF/GM-CSF
- (UMLS (NCI) C0281021) =Therapeutic or Preventive Procedure
| - 29. DCVax-Lung
- [A cancer vaccine consisting of lymphocytes harvested from a patient with lung cancer and induced to become antigen-presenting cells (APCs) known as dendritic cells. The dendritic cells are transduced with the gene encoding an antigen specific to the patient's cancer and then returned to the patient. In the host, the altered cells stimulate the immune system to mount a primary T cell response against lung tumor cells expressing the target antigen. Dendritic cell-autologous lung tumor vaccines have been investigated for use in cancer immunotherapy. (NCI04) ( NCI )] (UMLS (NCI) C1327750) Dendritic Cell-Autologous Lung Tumor Vaccine;
=Pharmacologic Substance; Immunologic Factor |
- 15. DCF/IFF/IFN-A
- (UMLS (NCI) C0338179) =Therapeutic or Preventive Procedure
| |
home
